This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.
1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors
ePostersLive by SciGen Technologies S.A. All rights reserved.
September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas
ABCL - 658
Aggressive B-Cell Lymphoma (ABCL)
Non-Hodgkin lymphoma; NHL; lymphoma mortality; NHL mortality; cancer mortality; mortality trends; mortality disparities; epidemiology; population-based study; United States; temporal trends; joinpoint regression; annual percent change; APC; rituximab; rituximab era; post-rituximab; COVID-19; COVID-19 pandemic; cancer outcomes; health disparities; racial disparities; ethnic disparities; age disparities; sex disparities; older adults; elderly; survival; therapeutic advances; immunotherapy; targeted therapy